FellowshipHands-on fellowship for aspiring biotech entrepreneurs in longevity.
age1
age1 is a venture capital firm based in the United States that funds early-stage companies focused on longevity and healthy aging. The firm supports contrarian founders developing innovative biotech solutions to address aging-related challenges.
Online destinations
Find age1 online
Where to find this organization online, grouped by who runs each page. A link here does not mean the organization controls it.
Official links
Pages the organization runs itself.
Overview
age1 is a venture capital firm dedicated to funding companies that aim to extend healthy lifespan through longevity research. Founded by Alex Colville and Laura Deming, age1 is based in the United States and focuses on supporting contrarian founders in building biotech companies that tackle the core challenges in the field of longevity. Launched in September 2023, age1 is positioned as a next-generation fund that continues the mission of The Longevity Fund, which was the first longevity-focused VC fund established in 2011. With a commitment to investing in early-stage companies, age1 typically engages before any funding has been raised, including angel rounds, pre-seed, seed, and series A. The firm is well-capitalized to support its portfolio companies through later funding rounds, with investments ranging from $500,000 to $4 million.
Focus
age1 invests primarily in early-stage companies, including pre-seed, seed, and series A rounds. The organization is well-capitalized to support its portfolio companies through later funding rounds, with investments ranging from $500,000 to $4 million. The focus is on exceptional founders globally who are developing therapeutics, tools, and technologies that target aging and age-related diseases.
Support
age1 provides significant value-add to its portfolio companies by leveraging its deep expertise in longevity research and a strong network within the biotech industry. The organization supports founders not only with capital but also with strategic guidance and resources to navigate the complexities of developing innovative therapies and technologies.
Questions
What are age1's investment criteria?
age1 invests in early-stage companies, focusing on angel, pre-seed, seed, and series A rounds. They look for exceptional founders who are developing innovative solutions in the longevity and healthcare sectors.
How can startups apply or pitch to age1?
Startups can pitch to age1 through their website at age1.com. They encourage founders to provide detailed information about their business model, team, and the problem they are solving in the longevity space.
What makes age1 different from other venture capital firms?
age1 is uniquely focused on longevity and healthy aging, investing in contrarian founders and innovative biotech solutions that target aging and age-related diseases. Their commitment to this niche sets them apart in the venture capital landscape.
What is age1's geographic scope?
age1 invests globally, with a particular emphasis on the United States. They seek exceptional founders from around the world who are addressing challenges in longevity.
What is the typical check size for investments?
age1 typically invests between $500,000 and $4 million, depending on the funding round and the specific needs of the portfolio company.
What kind of support does age1 provide to its portfolio companies?
age1 offers significant value-add through strategic guidance, resources, and access to a strong network within the biotech industry. They are committed to supporting their portfolio companies not only with capital but also with operational and strategic support.
Check your startup’s fit
Check your startup’s fit with age1Hosted by this organization
Programs at age1
FellowshipSimilar investors
Organizations that do similar work to age1.
InvestorFounders Fund is a venture capital firm based in the United States, founded in 2005. It invests in technology companies across various sectors and stages.
InvestorTransforming businesses for long-term success.
InvestorAndreessen Horowitz, also known as a16z, is a prominent venture capital firm based in Silicon Valley, founded in 2009. The firm invests across various sectors, supporting companies from early-stage startups to growth-stage firms.
InvestorSequoia Capital is a venture capital firm based in Silicon Valley, established in 1972. It invests in technology companies at various stages, focusing on long-term partnerships with founders.
Superscout Pro
Find faster. Show up verified. Keep your deals private.
$99a year, or $12 a month
Get Pro- Search that narrowsInvestors, programs, accelerators, incubators and studios, by stage, sector and place.
- A verified profileThe people you reach know you are who you say you are.
- A private deal vaultThe startups you are watching, with your notes and your reasons. Nobody else's eyes.
Is this page right?Reviewed · How the research works